Composite resection of posterior pelvic malignancy.

AUTOR(ES)

Wanebo, H J

RESUMO

Advanced pelvic cancer is a formidable challenge to surgical resection. These tumors commonly invade the bony pelvis, may involve other viscera, and usually have been irradiated previously. The authors are presenting experience with 76 patients who had composite resection of posterior or lateral pelvic malignancy. Fifty-eight patients had secondary cancers involving the musculoskeletal pelvis. This included 47 patients with advanced carcinoma of the rectum (41 curative, 6 palliative), 10 epidermoid cancers of the anorectum (8) or cervix (2), and 1 bladder cancer. Among the 18 patients with primary pelvic tumors were three patients with chordomas, six with bone tumors (osteosarcoma chondrosarcoma, grade III giant cell tumor), and nine with soft tissue tumors. All required major resection of the sacrum or pelvic side walls, and one half had an additional exenterative procedure. The overall mortality rate was 7.9%. Long-term estimated survival was 24% in patients having curative resection of recurrent rectal cancer, and 22.5% in 10 patients with advanced epidermoid cancer. Fifty per cent of patients with primary bone or soft tissue tumors survived from 13 to 88 months. Most patients had reasonable return of function, and were able to return to work or resume their normal previous lifestyle.

Documentos Relacionados

• A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy.
• Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy.
• Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis.
• A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy.
• Immunodiagnosis of human malignancy.